Institutional holders reduced positions by $10.17B in the latest quarter, with 718 net sellers versus 690 net buyers. Insiders sold $549k in the past 90 days with zero purchases, reinforcing selling pressure.

Confirmation

Increased insider selling cadence or additional institutional exodus would strengthen the bearish case.

Invalidation Risk

A sudden shift in institutional accumulation or insider buying would invalidate this verdict.

This game-theory analysis is AI-assisted and derived from public regulatory filings, covering historical data only. For informational purposes, not investment advice.

Insider Trading (Form 4)

90d confidence

unique buyers

—

buy value

data as of 2026-07-17

12-Month Buy/Sell Activity

Mar 25

Jul 25

Oct 25

Jan 26

BuySell

Action	Insider	Title	Date	Value
Sell	Feld Michael	EVP, Chief Revenue Officer	2026-03-26	$12K
Sell	Feld Michael	EVP, Chief Revenue Officer	2026-02-26	$14K
Sell	SCOTT BERTRAM L	Director	2026-02-18	$174K
Sell	Feld Michael	EVP, Chief Revenue Officer	2026-01-26	$15K
Sell	Garrison Michael David	EVP & Pres Med.Essntl&BioPharm	2026-01-15	$209K
Sell	Garrison Michael David	EVP & Pres Med.Essntl&BioPharm	2026-01-15	$125K
Sell	Feld Michael	EVP, Chief Revenue Officer	2025-12-26	$15K
Sell	Garrison Michael David	EVP & Pres Med.Essntl&BioPharm	2025-12-17	$123K

View all insider trades →

Form 144 Pre-Sale Notices

Filings (90d)

$337K

Total Est. Value

2K shares

Planned Shares

Last Filed 2026-06-26

Filer	Title/Relationship	Filing Date	Planned Shares	Est. Value
Feld Michael	Officer	2026-06-26	75 shares	$11K
Garrison Michael David	Officer	2026-06-24	1K shares	$158K
Garrison Michael David	Officer	2026-06-10	1K shares	$167K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding BECTON DICKINSON AND CO (BDX)?

Major stakeholders currently include BlackRock, Inc. ($4.1B), Vanguard Capital Management LLC ($2.9B), Vanguard Portfolio Management LLC ($2.4B). Based on the latest 13F filings, there are a total of 1465 tracked investment funds and institutions maintaining positions in BDX.

What is the overall institutional sentiment toward BDX recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $10.2B, driven by 692 managers accumulating shares while 718 reduced their exposure.

Which institutions have been selling or reducing their BDX positions?

In the latest period, 528 funds trimmed their holdings, and 190 managers completely exited their positions. The aggregate reported sell value was $26.1B.

Are there any notable investors adding BDX to their portfolios?

Yes, buying activity remains notable. 110 institutions opened new positions in {ticker}, and 582 existing holders added to their shares. The total reported buy value for the quarter amounted to $18.7B.